Berenberg Bank Reiterates “€70.95” Price Target for Fresenius SE & Co KGaA (FRE)

Fresenius SE & Co KGaA (FRA:FRE) has been given a €70.95 ($82.50) price objective by equities research analysts at Berenberg Bank in a report issued on Wednesday, Borsen Zeitung reports. The firm presently has a “buy” rating on the stock. Berenberg Bank’s target price would suggest a potential upside of 43.26% from the company’s current price.

Other equities analysts also recently issued research reports about the stock. Goldman Sachs Group set a €52.00 ($60.47) price target on shares of Fresenius SE & Co KGaA and gave the stock a “buy” rating in a research note on Friday, March 22nd. DZ Bank restated a “buy” rating on shares of Fresenius SE & Co KGaA in a research note on Tuesday, April 2nd. Independent Research set a €53.00 ($61.63) price target on shares of Fresenius SE & Co KGaA and gave the stock a “neutral” rating in a research note on Wednesday, February 20th. Deutsche Bank set a €65.00 ($75.58) price target on shares of Fresenius SE & Co KGaA and gave the stock a “buy” rating in a research note on Tuesday, February 12th. Finally, Kepler Capital Markets set a €58.00 ($67.44) price target on shares of Fresenius SE & Co KGaA and gave the stock a “buy” rating in a research note on Thursday, February 21st. Ten equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of €59.18 ($68.82).

FRA:FRE opened at €49.53 ($57.59) on Wednesday. Fresenius SE & Co KGaA has a 52 week low of €60.16 ($69.95) and a 52 week high of €80.00 ($93.02).

Fresenius SE & Co KGaA Company Profile

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Featured Article: What are Bollinger Bands?

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.